Consonance Capital Management LP Gamida Cell Ltd. Transaction History

Consonance Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.85 - $6.44 $11 Million - $18.4 Million	-2,858,558 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.85 - $8.33 $2.69 Million - $3.83 Million	-459,649 Reduced 13.85%	2,858,558 $18.3 Million
Q1 2021 May 17, 2021	BUY	$7.8 - $12.43 $237,603 - $378,642	30,462 Added 0.93%	3,318,207 $26.8 Million
Q4 2020 Feb 16, 2021	BUY	$4.07 - $11.0 $13.4 Million - $36.2 Million	3,287,745 New	3,287,745 $27.6 Million

2.2K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.